Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLS | AZN | AMGN | GILD | BMY |
| Company | Sellas Life Sciences Group Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 4.91 | 184.36 | 326.03 | 130.44 | 57.65 |
| High | 5.24 | 185.19 | 326.79 | 132.89 | 58.00 |
| Low | 4.90 | 183.66 | 323.21 | 130.00 | 56.93 |
| Latest | 5.05 | 183.41 | 324.51 | 132.35 | 57.27 |
| Change | +0.12 | -1.33 | -5.31 | +0.70 | -0.95 |
| % Change | +2.43% | -0.72% | -1.61% | +0.53% | -1.63% |
| Volume | 1,929,230 | 393,648 | 806,584 | 2,184,743 | 3,454,368 |
| 20-Day Average Volume | 4,285,711 | 1,977,634 | 2,486,041 | 5,248,832 | 9,606,053 |
| Previous Close | 4.93 | 184.74 | 329.82 | 131.65 | 58.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.86 | 195.80 | 345.12 | 135.17 | 58.64 |
| 20-Day Raw Stochastic | 70.98% | 8.49% | 3.26% | 28.96% | 6.66% |
| 20-Day Relative Strength | 54.38 | 38.82 | 35.98 | 42.13 | 45.44 |
| Weighted Alpha | +158.45 | +28.45 | +15.18 | +28.29 | +23.45 |
| Today's Opinion | 72% Buy | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 72% Buy | 24% Buy | 8% Sell | 8% Buy | 40% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.72% since 04/27/26 | -1.93% since 04/27/26 | -4.64% since 04/27/26 | +3.39% since 04/27/26 | -1.00% since 04/27/26 |
| Low | 4.66 on 04/29/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.96 on 04/30/26 | 56.95 on 05/04/26 |
| High | 5.24 on 05/04/26 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 132.89 on 05/04/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +23.73% since 04/02/26 | -9.63% since 04/02/26 | -6.77% since 04/02/26 | -5.46% since 04/02/26 | -4.02% since 04/02/26 |
| Low | 4.20 on 04/06/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.64 on 04/27/26 | 56.95 on 05/04/26 |
| High | 5.47 on 04/20/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +33.77% since 02/04/26 | -1.89% since 02/04/26 | -11.42% since 02/04/26 | -9.68% since 02/04/26 | -0.72% since 02/04/26 |
| Low | 3.46 on 02/12/26 | 181.73 on 04/29/26 | 323.21 on 05/04/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 6.14 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +207.84% since 11/04/25 | +12.09% since 11/04/25 | +9.33% since 11/04/25 | +7.38% since 11/04/25 | +25.48% since 11/04/25 |
| Low | 1.39 on 12/02/25 | 162.04 on 11/05/25 | 302.13 on 11/05/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 6.14 on 03/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 909,748 | 286,514,752 | 177,998,896 | 163,406,864 | 118,869,808 |
| Shares Outstanding, K | 184,533 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -26,860,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -7,660,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.24 | 0.26 | 0.44 | 0.32 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 03/19/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/12/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.67 | 16.05 | 10.22 |